We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App





Scientists Use Cloud-Based Supercomputing and AI to Develop COVID-19 Treatments and Vaccine Models

By HospiMedica International staff writers
Posted on 16 Sep 2020
Print article
Image: Covax-19 (Photo courtesy of Vaxine Pty Ltd.)
Image: Covax-19 (Photo courtesy of Vaxine Pty Ltd.)
A team of scientists from a vaccination biotech company have used cloud-based supercomputing and artificial intelligence (AI) to develop COVID-19 treatments and vaccine models.

The research team from Vaxine Pty Ltd. (Adelaide, Australia) used computer modelling on the coronavirus spike protein to rapidly design a synthetic COVID-19 vaccine. The Vaxine team was able to design, manufacture and advance their Covax-19 vaccine into human trials in under five months in a process that normally would take up to 15 years. The team is also using similar techniques for other projects, including a new treatment for respiratory complications of COVID-19, a preventive nasal spray, and a rapid response test to predict how severely the disease will progress.

Recently, the Vaxine research group released a list of up to 80 new potential candidate drugs against the COVID-19 virus. The possible therapies were identified using cloud-based supercomputer programs used by Vaxine in its vaccination research modelling, allowing other researchers to further investigate their potential. Using the genetic sequence of COVID-19, the team built three dimensional molecular structures of key COVID-19 proteins that were then used to screen existing drugs and natural remedies for potential activity against the COVID-19 protease protein. The team used high performance cloud computing services provided by Oracle under a research grant to Flinders University (Adelaide, South Australia) that enabled the team to rapidly screen for potential drugs against COVID-19.

“Thanks to our unique ability to run computer simulations on the virus before it is even fully characterized, we were able to dramatically speed up the ability to design our Covax-19 vaccine,” said Flinders University Professor Nikolai Petrovsky, Research Director of Vaxine. “The vaccine based on the synthetic spike protein was then manufactured in insect cell cultures before being combined with our Vaxine Advax adjuvant, which is used to turbocharge the vaccine and make it more effective.”

“It is exciting to be at the forefront of global COVID-19 science efforts, applying all the latest cutting edge methods including artificial intelligence and high performance cloud computing to create potential pandemic drugs and vaccines as part of the Vaxine team,” said Dr. Sakshi Piplani, who leads Vaxine’s bioinformatics team.

Related Links:
Vaxine Pty Ltd.
Flinders University


Gold Supplier
SBRT Phantom with Removable Spine
E2E SBRT Phantom with Removable Spine Model 036S-CVXX-xx
New
Eye Protector
Biliband
New
Capnograph/Pulse Oximeter
Handleld Capnograph/Pulse Oximeter
New
Blood Warmer
SAHARA-III 230 V

Print article

Channels

AI

view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Critical Care

view channel
Image: The advanced electronic skin could enable multiplex healthcare monitoring (Photo courtesy of Terasaki Institute)

First-of-Its-Kind Electronic Skin Patch Enables Advanced Health Care Monitoring

For some time now, electronic skin (E-skin) patches have been used to monitor bodily physiological and chemical indicators of health. Such monitors, placed on the skin, are capable of measuring various... Read more

Surgical Techniques

view channel
Image: The neuro-chip with soft implantable electrodes could manage brain disorders (Photo courtesy of EPFL)

Implantable Neuro-Chip Uses Machine Learning Algorithm to Detect and Treat Neurological Disorders

Using a combination of low-power chip design, machine learning algorithms, and soft implantable electrodes, researchers have produced a neural interface that can identify and suppress symptoms of different... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: Researchers expect broader adoption of AI in healthcare in the near future (Photo courtesy of Pexels)

Artificial Intelligence (AI) Could Save U.S. Healthcare Industry USD 360 Billion Annually

The wider adoption of artificial intelligence (AI) in healthcare could save the U.S. up to USD 360 billion annually although its uptake in the industry is presently limited owing to the absence of trust... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.